Advertisement

Ads Placeholder
Loading...

Cronos Group Inc.

CRON•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$2.53
$0.02(0.80%)
U.S. Market opens in 0h 26m

Cronos Group Inc. (CRON) Stock Overview

Explore Cronos Group Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap973.1M
P/E Ratio-103.19
EPS (TTM)$-0.02
ROE-0.01%
Fundamental Analysis

AI Price Forecasts

1 Month$2.27
3 Months$3.22
1 Year Target$3.04

CRON Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Cronos Group Inc. (CRON) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 48.69, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $3.04.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -103.19 and a market capitalization of 973.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.80%
5-Day Change
0.80%
1-Month Change
-2.69%
3-Month Change
-6.30%
6-Month Change
-1.94%
Year-to-Date (YTD) Change
-6.30%
1-Year Change
42.13%
3-Year Change
29.74%
5-Year Change
-72.88%
All-Time (Max) Change
1433.33%

Contact Information

https://www.thecronosgroup.com
14165040004
111 Peter Street, Stayner, ON, M5V 2H1

Company Facts

4,590 Employees
IPO DateFeb 27, 2018
CountryCA
Actively Trading

Frequently Asked Questions